Benzinga | Jul 17, 2020 02:45PM EDT

BioSig Shares See Volume Following Co. Press Release Highlighting Co. Will Participate In B Riley FBR Virtual Infectious Disease Summit On Jul 21.

BioSig Technologies, Inc. (NASDAQ:BSGM) ("BioSig" or the "Company"), a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that Jerry Zeldis, M.D., Ph.D., Chief Medical Officer of ViralClear Pharmaceuticals, Inc. , a majority owned subsidiary of BioSig, will be participating in the B Riley FBR Infectious Disease Summit -- Part III: Therapeutics "Fast and Curious: Race to Finding Cures for Several Infectious Diseases, Including COVID-19" on July 21, 2020. The panel segment is "Arresting the Viral Replication Cycle."

Speaking Information:

Event: B. Riley FBR Virtual Infectious Disease Summit - Part III: Therapeutics "Fast and Curious: Race to Finding Cures for Several Infectious Diseases, Including COVID-19"

Panel: Arresting the Viral Replication Cycle

Date: Tuesday, July 21, 2020

Time: 1:15 PM ET

If you are an institutional investor and would like to attend the event, please contact Andrew Ballou, Vice President, Investor Relations ataballou@biosigtech.com.